ArticlePloS one2012

NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

Alexandra Hebar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.